INM
Price
$2.06
Change
-$0.10 (-4.63%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.15M
Intraday Buy/Sell Signals
IXHL
Price
$0.35
Change
-$0.01 (-2.78%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
124.1M
Intraday Buy/Sell Signals
Interact to see
Advertisement

INM vs IXHL

Header iconINM vs IXHL Comparison
Open Charts INM vs IXHLBanner chart's image
InMed Pharmaceuticals
Price$2.06
Change-$0.10 (-4.63%)
Volume$1.45K
Capitalization5.15M
Incannex Healthcare
Price$0.35
Change-$0.01 (-2.78%)
Volume$47.3K
Capitalization124.1M
INM vs IXHL Comparison Chart in %
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. IXHL commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and IXHL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (INM: $2.16 vs. IXHL: $0.36)
Brand notoriety: INM and IXHL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INM: 37% vs. IXHL: 20%
Market capitalization -- INM: $5.15M vs. IXHL: $124.1M
INM [@Pharmaceuticals: Generic] is valued at $5.15M. IXHL’s [@Pharmaceuticals: Generic] market capitalization is $124.1M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.74B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileIXHL’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • IXHL’s FA Score: 0 green, 5 red.
According to our system of comparison, INM is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 3 TA indicator(s) are bullish while IXHL’s TA Score has 3 bullish TA indicator(s).

  • INM’s TA Score: 3 bullish, 6 bearish.
  • IXHL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both INM and IXHL are a bad buy in the short-term.

Price Growth

INM (@Pharmaceuticals: Generic) experienced а -1.82% price change this week, while IXHL (@Pharmaceuticals: Generic) price change was -6.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.03%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +42.81%.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.03% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IXHL($124M) has a higher market cap than INM($5.15M). INM YTD gains are higher at: -52.941 vs. IXHL (-83.165). INM has higher annual earnings (EBITDA): -7.86M vs. IXHL (-21.34M). IXHL has more cash in the bank: 6.71M vs. INM (4.68M). INM has less debt than IXHL: INM (849K) vs IXHL (1.69M). INM has higher revenues than IXHL: INM (4.92M) vs IXHL (98K).
INMIXHLINM / IXHL
Capitalization5.15M124M4%
EBITDA-7.86M-21.34M37%
Gain YTD-52.941-83.16564%
P/E Ratio0.01N/A-
Revenue4.92M98K5,021%
Total Cash4.68M6.71M70%
Total Debt849K1.69M50%
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMIXHL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 20 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOYFF33.60N/A
N/A
Huhtamaki Oy
IRMTF26.12N/A
N/A
Information Svcs Corp
JDEPF36.00N/A
N/A
JDE Peet's NV
OAKV13.31-0.01
-0.08%
OAK VIEW BANKSHARES INC.
ARWYF0.06-0.01
-16.62%
ARWAY CORP.

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with HYPD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
+0.47%
HYPD - INM
39%
Loosely correlated
-0.66%
OMER - INM
36%
Loosely correlated
-4.61%
VTYX - INM
31%
Poorly correlated
+1.35%
RVPH - INM
30%
Poorly correlated
-2.86%
PULM - INM
30%
Poorly correlated
-1.36%
More

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and INM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-6.08%
INM - IXHL
24%
Poorly correlated
+0.47%
ESPR - IXHL
23%
Poorly correlated
-1.06%
NBIX - IXHL
22%
Poorly correlated
+0.93%
HROW - IXHL
22%
Poorly correlated
-3.11%
YCBD - IXHL
20%
Poorly correlated
-7.83%
More